v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (5,078,498) $ (3,356,535)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense, net 2,634,563 663,051
Changes in operating assets and liabilities, net    
Other current assets (586,757) 14,014
In-process research and development accrued expenses (3,000,000) 0
Accounts payable, accrued expenses and other current liabilities (705,565) (656,989)
Operating lease right-of-use assets and liabilities, net (4,430) 4,238
Net cash used in operating activities (6,740,687) (3,332,221)
Cash flows from investing activities:    
Purchase of short-term investments (3,138,534) (985,730)
Maturities of short-term investments 4,000,000 0
Net cash provided by (used in) investing activities 861,466 (985,730)
Cash flows from financing activities:    
Cash proceeds from the sales of common stock under a Capital on DemandTM Sales Agreement 0 3,192,618
Taxes paid related to net share settlement of vested restricted stock units (452,684) (20,740)
Cash proceeds from the issuance of stock upon exercise of stock options 20,157 84
Net cash (used in) provided by financing activities (432,527) 3,171,962
Effect of exchange rates (2,605) (160)
Net decrease in cash and cash equivalents (6,314,353) (1,146,149)
Cash and cash equivalents at beginning of period 45,816,289 7,266,080
Cash and cash equivalents at end of period 39,501,936 6,119,931
Supplemental non-cash flow information:    
Lease liability arising out of obtaining right-of-use asset $ 127,342 $ 0